Blog – Clinical Trial Results

Dr. Robin Nijveldt and Dr. C. Michael Gibson Discuss: iMODERN:iFR- vs. Cardiac MRI-Guided Revascularization of Non-Culprit Lesions in STEMI

October 28, 2025

Disclosures: TBD

Dr. Shamir R. Mehta and Dr. C. Michael Gibson Discuss: STRIVE:Low-Dose r-tPA vs. Placebo in STEMI With Large Thrombus Burden

October 28, 2025

Disclosures: TBD

Dr. Ruben de Winter and Dr. C. Michael Gibson Discuss: PROCTOR:Native Vessel vs. SVG PCI in Patients With Prior CABG

October 28, 2025

Disclosures: TBD

Dr. Matthias Bossard and Dr. C. Michael Gibson Discuss: VICTORY:Intravascular Lithotripsy vs. Super-High-Pressure PTCA in Calcified and Refractory Coronary Lesions

October 26, 2025

Disclosures: TBD

Dr. Suzanne J. Baron and Dr. C. Michael Gibson Discuss: Short-CUT: Intravascular Lithotripsy vs. Cutting Balloon Angioplasty in Calcified CAD

October 26, 2025

Disclosures: TBD

Dr. Donald Cutlip and Dr. C. Michael Gibson Discuss: SELUTION4ISR: Sirolimus-Eluting DCB vs. DES or Balloon Angioplasty for In-Stent Restenosis

October 26, 2025

Disclosures: TBD

Dr. Christian M. Spaulding and Dr. C. Michael Gibson Discuss: SELUTION DeNovo: Sirolimus-Eluting DCB vs. DES in De Novo Coronary Lesions

October 26, 2025

Disclosures: TBD

Dr. Marc Bonaca and Dr. C Michael Gibson discuss: When is the world ready for Asymptomatic CAD Screening?

October 20, 2025

Sponsored by Cleerly, Women as One, and International Atherosclerosis Society

Dr. Danielle Belardo and Dr. C. Michael Gisbon discuss: The Target is the Plaque: Stabilization, Regression, and the Role of Imaging and AI in Modern CAD Management

October 2, 2025

Sponsored by Cleerly, Women as One and International Atherosclerosis Society

Dr. Masri and Dr. C. Michael Gibson discuss: Effect of Acoramidis on Recurrent and Cumulative Cardiovascular Outcomes in ATTR-CM: Exploratory Analysis from ATTRibute-CM

October 1, 2025

Disclosures: Supported by an independent educational grant from BridgeBio Pharma Inc.